FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia
Data on the possibilities of using the bioregulatory peptide Prostatex is presented in the literature review, based on results of various studies for different prostate diseases.
prostate diseases
bioregulatory peptides
Prostatex
Corresponding author: Z.K. Gadzhieva – Ph.D., MD, Head of the Department of analysis of personnel policy, educational programs and scientific research of the National Medical Research Center for «Urology», FGAOU VO I.M. Sechenov First Moscow State Medical University, scientific editor of the journal “Urologiia”, deputy Executive Director of the Russian Society of Urology, Moscow, Russia; e-mail:
zgadzhieva@ooorou.ru